Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo-controlled trial

Akhondzadeh, Shahin; Noroozıan, Maryam; Mohammadi, M.; Ohadinia, Sina; H Jamshidi, A; Khani, M

doi:10.1046/j.1365-2710.2003.00463.x

Public

Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo-controlled trial

Published in Journal of Clinical Pharmacy and Therapeutics • Feb 1, 2003

Authors:

Shahin Akhondzadeh

Maryam Noroozıan

M. Mohammadi

Abstract

BACKGROUND: Alzheimer's disease is characterized by a slow, progressive decline in cognitive function and behaviour. Acetylcholine esterase inhibitors are the only agents approved by the Food and Drug Administration for the treatment of Alzheimer's disease. All other agents prescribed for the treatm...

Subject

Salvia officinalis

Medicine

Placebo

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!